SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-19-000006
Filing Date
2019-01-03
Accepted
2019-01-03 11:59:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A SLS 1.103.19 sls0119.txt SC 13G/A 13714
  Complete submission text file 0001535610-19-000006.txt   15568
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Subject) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-84090 | Film No.: 19504139
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A